All News
CordenPharma invests heavily in peptides
Andrew Warmington
Feature article – US agrochemicals: A delicate balance
Andrew Warmington
FMC exits non-crop business
Andrew Warmington
Feature article – UK REACH ATRm: Four amber flags & an opportunity
Andrew Warmington
Eurofins in war of words with ‘activist short seller’
Andrew Warmington
OQ Chemicals for sale?
Andrew Warmington
Activist’ shareholder cranks up pressure on Elementis
Andrew Warmington
Kemira expands water treatment offer
Andrew Warmington
Syensqo, Allozymes sign MoU
Andrew Warmington
Navin Molecular expands
Andrew Warmington
PI bids for Plant Health Care
Andrew Warmington
Feature article – Saltigo rides out the cycle
Andrew Warmington